Answers are grounded in this paper and cite their sources.
This systematic review and meta-analysis evaluated the effectiveness of brief Acceptance and Commitment Therapy (ACT), operationalized using modality-specific thresholds (individual: ≤6 sessions/≤6 hours; group: ≤6 weeks/≤12 hours), on depression and anxiety across mental health, physical/medical, and non-clinical populations. Forty-nine RCTs were included in the review. Random-effects models (Hedges’ g) were used, with subgroup analyses by control condition and population type. (PROSPERO registration: CRD42024531152). For depression (k = 41), brief ACT showed a moderate overall effect (g = 0.56; I2 = 90.61%), significant versus passive (g = 0.67) but not active controls (g = 0.14). For anxiety (k = 35), a small-to-moderate overall effect emerged (g = 0.42; I2 = 86.22%), significant versus passive (g = 0.53) but not active controls (g = 0.01). For depressive symptoms, significant effects were observed in mental health and physical/medical populations, but not non-clinical populations. For anxiety symptoms, the pooled effect reached significance in non-clinical populations but not mental health or physical/medical populations; tests of between-subgroup differences were non-significant. Brief ACT was associated with reduced depression and anxiety relative to passive controls, but not active interventions, and heterogeneity was substantial. Brief ACT may serve as a viable option in resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Kempe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: